ZSRM:F:F-BNP Paribas Easy MSCI USA SRI S-Series PAB 5% Capped UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 20.14

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.07 (+0.27%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.11 (+0.22%)

USD 113.22B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.30 (-0.25%)

USD 83.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.13 (+0.25%)

USD 77.76B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.05 (+0.21%)

USD 73.13B
EUNL:F iShares Core MSCI World UCITS ..

-0.07 (-0.07%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.45 (-0.20%)

USD 56.29B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.04 (+0.28%)

USD 54.81B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.24 (-0.25%)

USD 51.63B

ETFs Containing ZSRM:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.73% 44% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.73% 42% F 49% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike